The change made all the difference
ROS dysregulation in cardiovascular diseases ROS dysregulation represents a central node in cardiovascular diseases progression [314], involving endothelial dysfunction [315], cardiomyocyte injury [316], mitochondrial [317] and endoplasmic reticulum stress [318], vascular remodeling [319], and atherosclerosis [320]
Background and Summary of Retrospective Studies Homocystinuria caused by congenital CBS and MTHFR defects or by genetic alteration of cobalamin metabolism is characterized by clinical problems including frequent arterial and venous thromboembolism and premature atherosclerosis (McCully, 1983
If more than 2 consecutive doses are missed, resume at a lower dose or contact your healthcare provider, as re-titration may be needed to minimize gastrointestinal side effects
Supplementary Figure 1
Preparation: A nurse prepares the IV drip, often with vitamin C for enhanced absorption